Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Isu Abxis Co. Ltd.

Headquarters: Seongnam, South Korea
Year Founded: 2001
Status: Public
Industry Sector: HealthTechnology
CEO: Yup Hwang, MBA
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: 13.58
Exchange/Ticker 1: KOSDAQ:086890
Exchange/Ticker 2: N/A
Latest Market Cap: $132,124,486

BioCentury | Jun 4, 2022
Product Development

New modalities give HER3 another shot at ASCO

ASCO data from Daiichi, Merus show anti-HER3 efficacy in challenging indications
BioCentury | Jun 22, 2018
Clinical News

Antibodies neutralize Catalyst's Factor IX variant

BioCentury | Sep 19, 2016
Company News

Catalyst Biosciences hematology news

BioCentury | Apr 6, 2015
Company News

Catalyst Biosciences, Targacept deal

BioCentury | Oct 14, 2013
Company News

Catalyst Biosciences, Isu Abxis deal

BioCentury | Oct 14, 2013
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
Items per page:
1 - 8 of 8
Help Center
Username
Request a Demo
Request Training
Ask a Question